Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 13 | 2021 | 131 | 2.040 |
Why?
|
| Subarachnoid Hemorrhage | 9 | 2021 | 68 | 1.130 |
Why?
|
| Consciousness Disorders | 1 | 2022 | 12 | 0.860 |
Why?
|
| Critical Illness | 1 | 2022 | 127 | 0.760 |
Why?
|
| Brain Diseases | 1 | 2021 | 83 | 0.730 |
Why?
|
| Hospital Mortality | 8 | 2022 | 140 | 0.700 |
Why?
|
| Fever | 1 | 2017 | 40 | 0.560 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2021 | 96 | 0.410 |
Why?
|
| Time Factors | 11 | 2020 | 1641 | 0.380 |
Why?
|
| Drainage | 3 | 2021 | 50 | 0.360 |
Why?
|
| Humans | 32 | 2022 | 29811 | 0.360 |
Why?
|
| Brain Ischemia | 2 | 2021 | 72 | 0.340 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 118 | 0.340 |
Why?
|
| Stroke | 4 | 2017 | 294 | 0.340 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 1126 | 0.320 |
Why?
|
| Female | 22 | 2021 | 16410 | 0.320 |
Why?
|
| Cerebral Infarction | 2 | 2021 | 154 | 0.300 |
Why?
|
| Brain Edema | 2 | 2020 | 23 | 0.290 |
Why?
|
| Encephalocele | 2 | 2020 | 26 | 0.290 |
Why?
|
| Retrospective Studies | 11 | 2021 | 3325 | 0.290 |
Why?
|
| Middle Aged | 18 | 2021 | 9960 | 0.290 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2019 | 11 | 0.280 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 34 | 0.280 |
Why?
|
| Male | 22 | 2021 | 15850 | 0.280 |
Why?
|
| Risk Factors | 8 | 2021 | 2465 | 0.270 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 57 | 0.270 |
Why?
|
| Cerebral Ventricles | 2 | 2017 | 23 | 0.260 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 42 | 0.250 |
Why?
|
| Hydrocephalus | 2 | 2021 | 28 | 0.240 |
Why?
|
| Prospective Studies | 8 | 2021 | 1823 | 0.230 |
Why?
|
| Intracranial Thrombosis | 2 | 2020 | 6 | 0.220 |
Why?
|
| Consciousness | 1 | 2022 | 6 | 0.210 |
Why?
|
| Weather | 2 | 2019 | 18 | 0.200 |
Why?
|
| Length of Stay | 3 | 2021 | 320 | 0.200 |
Why?
|
| Aged | 15 | 2021 | 9620 | 0.200 |
Why?
|
| Hospitals | 1 | 2022 | 157 | 0.190 |
Why?
|
| Pandemics | 2 | 2020 | 237 | 0.190 |
Why?
|
| Leukocytosis | 1 | 2021 | 8 | 0.190 |
Why?
|
| Cerebrum | 1 | 2021 | 10 | 0.190 |
Why?
|
| Critical Care | 2 | 2020 | 242 | 0.190 |
Why?
|
| Hospitalization | 2 | 2020 | 319 | 0.190 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 11 | 0.190 |
Why?
|
| Brain Death | 1 | 2020 | 16 | 0.190 |
Why?
|
| Neurologists | 1 | 2020 | 8 | 0.180 |
Why?
|
| Occupational Health | 1 | 2020 | 21 | 0.180 |
Why?
|
| Health Care Rationing | 1 | 2020 | 7 | 0.180 |
Why?
|
| Apnea | 1 | 2020 | 17 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 34 | 0.180 |
Why?
|
| Cerebral Angiography | 3 | 2021 | 30 | 0.180 |
Why?
|
| Rivaroxaban | 1 | 2020 | 8 | 0.180 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 9 | 0.180 |
Why?
|
| Logistic Models | 3 | 2017 | 410 | 0.180 |
Why?
|
| Hemostasis | 1 | 2020 | 11 | 0.180 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 5 | 0.180 |
Why?
|
| Pyridones | 1 | 2020 | 14 | 0.180 |
Why?
|
| Hemostatics | 1 | 2020 | 12 | 0.180 |
Why?
|
| Risk Assessment | 3 | 2021 | 683 | 0.180 |
Why?
|
| Blood Coagulation Factors | 1 | 2020 | 18 | 0.180 |
Why?
|
| Pregnancy | 1 | 2021 | 386 | 0.180 |
Why?
|
| Prognosis | 3 | 2020 | 874 | 0.180 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 67 | 0.180 |
Why?
|
| Seizures | 1 | 2020 | 88 | 0.180 |
Why?
|
| Blood Glucose | 1 | 2020 | 112 | 0.170 |
Why?
|
| Endocarditis | 1 | 2019 | 9 | 0.170 |
Why?
|
| Electroencephalography | 1 | 2020 | 142 | 0.170 |
Why?
|
| Vasospasm, Intracranial | 1 | 2019 | 17 | 0.170 |
Why?
|
| Pyrazoles | 1 | 2020 | 50 | 0.170 |
Why?
|
| Brain Injuries | 1 | 2019 | 48 | 0.170 |
Why?
|
| Neurology | 1 | 2020 | 105 | 0.170 |
Why?
|
| Disease Management | 1 | 2019 | 122 | 0.160 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 332 | 0.160 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 214 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 86 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 89 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 149 | 0.160 |
Why?
|
| Adult | 10 | 2021 | 8741 | 0.140 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2017 | 1 | 0.140 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 11 | 0.140 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 66 | 0.140 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 147 | 0.140 |
Why?
|
| Sodium Chloride | 1 | 2017 | 37 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2017 | 286 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 350 | 0.130 |
Why?
|
| Chicago | 4 | 2020 | 866 | 0.120 |
Why?
|
| Thrombolytic Therapy | 2 | 2013 | 55 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2021 | 3561 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 4930 | 0.120 |
Why?
|
| Troponin I | 1 | 2013 | 11 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 14 | 0.110 |
Why?
|
| Young Adult | 5 | 2019 | 1966 | 0.110 |
Why?
|
| Community Health Centers | 1 | 2012 | 12 | 0.100 |
Why?
|
| Warfarin | 1 | 2012 | 38 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 532 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 8 | 0.100 |
Why?
|
| Transportation of Patients | 1 | 2011 | 6 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2012 | 102 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 778 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 1247 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 5 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 16 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 20 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 44 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 221 | 0.090 |
Why?
|
| Leukocyte Count | 2 | 2021 | 92 | 0.080 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 12 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2021 | 151 | 0.080 |
Why?
|
| Brain Infarction | 1 | 2009 | 74 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 283 | 0.080 |
Why?
|
| Age Factors | 2 | 2020 | 853 | 0.070 |
Why?
|
| Incidence | 2 | 2019 | 759 | 0.070 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2017 | 9 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2020 | 291 | 0.060 |
Why?
|
| Biomarkers | 2 | 2020 | 704 | 0.060 |
Why?
|
| United States | 2 | 2020 | 2344 | 0.060 |
Why?
|
| Hypertension | 2 | 2018 | 272 | 0.060 |
Why?
|
| Weaning | 1 | 2021 | 5 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 10 | 0.050 |
Why?
|
| Brain | 2 | 2021 | 1726 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 30 | 0.050 |
Why?
|
| Patient Admission | 1 | 2021 | 30 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2020 | 60 | 0.050 |
Why?
|
| Registries | 2 | 2012 | 191 | 0.050 |
Why?
|
| Pharmacists | 1 | 2020 | 16 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 23 | 0.050 |
Why?
|
| Critical Care Nursing | 1 | 2020 | 12 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2020 | 20 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 38 | 0.050 |
Why?
|
| Self Concept | 1 | 2020 | 46 | 0.050 |
Why?
|
| Triage | 1 | 2020 | 23 | 0.050 |
Why?
|
| Physician Assistants | 1 | 2020 | 18 | 0.050 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2019 | 9 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 109 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2019 | 24 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 24 | 0.040 |
Why?
|
| Nurses | 1 | 2020 | 46 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 88 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 53 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 142 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 75 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 558 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 156 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 74 | 0.040 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 106 | 0.040 |
Why?
|
| Physicians | 1 | 2020 | 116 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 327 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 354 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 504 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 221 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2020 | 230 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 331 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 497 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2017 | 20 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 312 | 0.040 |
Why?
|
| Leukocytes | 1 | 2017 | 45 | 0.040 |
Why?
|
| Glucose | 1 | 2017 | 60 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 802 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1462 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 346 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2012 | 9 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 23 | 0.030 |
Why?
|
| Plasma | 1 | 2012 | 34 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2013 | 522 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 194 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2010 | 9 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 11 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 494 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 2332 | 0.020 |
Why?
|